Thymosin Alpha-1 (TA-1)
$234.00
Thymosin Alpha-1 (TA-1) is a naturally occurring peptide derived from the thymus gland, best known for its immune-enhancing, anti-inflammatory, and antiviral properties. It plays a key role in immune system regulation, especially in modulating T-cell activity and enhancing host defense mechanisms. TA-1 has been widely studied for its role in chronic infections,
autoimmune diseases, and cancer immunotherapy.
It is used in clinical research for immune restoration in patients with chronic viral illnesses (such as hepatitis B/C), HIV, and COVID-19, as well as in anti-aging and vaccine support protocols. You can buy Thymosin Alpha-1 online from trusted peptide research suppliers.
Key Benefits
• Immune System Enhancement – Strengthens innate and adaptive immunity by activating T-cells and dendritic cells.
• Antiviral Effects – Helps fight viral infections by enhancing the body’s natural defense response.
• Reduces Inflammation – Modulates cytokine release to reduce chronic inflammation and autoimmunity.
• Supports Cancer Immunotherapy – Studied for use as an immune adjuvant in cancer treatments.
• Helps in Vaccine Response – Enhances immune response to vaccines, especially in immunocompromised subjects.
Mechanism of Action
• TA-1 activates T-lymphocytes, natural killer (NK) cells, and dendritic cells, supporting immune surveillance and pathogen elimination.
• Regulates cytokine production, including interferon-gamma (IFN-γ) and interleukin-2 (IL-2), to restore immune balance.
• Enhances expression of MHC class I molecules, improving antigen recognition and immune targeting.
Dosage Recommendations
• Typical Dosage – 1.6 mg to 3.2 mg per week in divided doses is common in immune- focused research.
• Administration – Administered via subcutaneous injection, typically 2–3 times weekly.
• Cycling – Used in 4–12 week research cycles, with variations depending on immune recovery or disease models.
Research and Studies
• Extensively studied for chronic infections like Hepatitis B and C, HIV, and COVID-19.
• Demonstrated benefits as an immunoadjuvant in cancer therapy, especially in melanoma and lung cancer research.
• Being investigated for sepsis, autoimmune diseases, and immunosenescence (age- related immune decline).
Possible Side Effects and Contraindications
• Common Side Effects – Generally well-tolerated; mild fatigue or injection site redness may occur.
• Precautions – Use cautiously in transplant or autoimmune models without proper monitoring.
• Drug Interactions – May enhance effects of vaccines or immunotherapy drugs; avoid unsupervised stacking with other immunostimulants.
Storage and Handling Instructions
• Store reconstituted TA-1 in a refrigerator at 2–8°C (36–46°F).
• Lyophilized powder should be kept in a cool, dry, dark location until reconstitution.
• Use sterile technique when handling to ensure peptide stability and purity.
Frequently Asked Questions (FAQs)
• How is TA-1 different from Thymogen or TB-500?
TA-1 focuses primarily on immune modulation, while Thymogen also supports epithelial healing, and TB-500 emphasizes tissue repair and inflammation control.
• Can TA-1 be used in aging or immune-compromised models?
Yes, it’s often studied in elderly or immune-suppressed populations for immune restoration and improved resilience.
• When are effects typically seen in research?
Immune biomarker changes can appear within 1–2 weeks, with more substantial clinical benefits over 4–8 weeks.
Medical Disclaimer
Thymosin Alpha-1 (TA-1) is intended for research and educational purposes only. It is not approved for human consumption or to diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any research protocol.
Related products
